Beta-glucans from edible mushrooms and immune modulation in humans: a systematic review
Murphy EJ, Rezoagli E, Major I
Published in Journal of Fungi
Key Findings
Mushroom beta-glucans alter cytokine and NK-cell measures in human trials, but clinically meaningful outcomes such as infection rates are rarely reported.
Conclusions
Immune marker changes have not translated into hard outcomes.
Limitations
Heterogeneous products and doses.
Supplements Studied
Mushroom beta-glucans change immune markers in humans, but clinically meaningful outcomes are rarely reported.
Mushroom beta-glucans alter cytokine and NK-cell measures in human trials, but clinically meaningful outcomes such as infection rates are rarely reported.
Outcomes Measured
Mushroom beta-glucans alter cytokine and NK-cell measures without demonstrated effects on infection rates.
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.